Literature DB >> 9449982

Isoforms of acetyl-CoA carboxylase: structures, regulatory properties and metabolic functions.

R W Brownsey1, R Zhande, A N Boone.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9449982     DOI: 10.1042/bst0251232

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  21 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 2.  Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis.

Authors:  Amin Gasmi; Massimiliano Peana; Maria Arshad; Monica Butnariu; Alain Menzel; Geir Bjørklund
Journal:  Arch Toxicol       Date:  2021-03-02       Impact factor: 5.153

3.  Multiple-site phosphorylation of the 280 kDa isoform of acetyl-CoA carboxylase in rat cardiac myocytes: evidence that cAMP-dependent protein kinase mediates effects of beta-adrenergic stimulation.

Authors:  A N Boone; B Rodrigues; R W Brownsey
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

4.  Role of an essential acyl coenzyme A carboxylase in the primary and secondary metabolism of Streptomyces coelicolor A3(2).

Authors:  E Rodríguez; C Banchio; L Diacovich; M J Bibb; H Gramajo
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

5.  Genomic distribution of three promoters of the bovine gene encoding acetyl-CoA carboxylase alpha and evidence that the nutritionally regulated promoter I contains a repressive element different from that in rat.

Authors:  J Mao; S Marcos; S K Davis; J Burzlaff; H M Seyfert
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

Review 6.  GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH).

Authors:  Naim Alkhouri; Eric Lawitz; Mazen Noureddin; Ralph DeFronzo; Gerald I Shulman
Journal:  Expert Opin Investig Drugs       Date:  2019-09-19       Impact factor: 6.206

7.  Abundance and diversity of archaeal accA gene in hot springs in Yunnan Province, China.

Authors:  Zhao-Qi Song; Li Wang; Feng-Ping Wang; Hong-Chen Jiang; Jin-Quan Chen; En-Min Zhou; Feng Liang; Xiang Xiao; Wen-Jun Li
Journal:  Extremophiles       Date:  2013-08-06       Impact factor: 2.395

8.  Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood.

Authors:  Clara D van Karnebeek; William S Sly; Colin J Ross; Ramona Salvarinova; Joy Yaplito-Lee; Saikat Santra; Casper Shyr; Gabriella A Horvath; Patrice Eydoux; Anna M Lehman; Virginie Bernard; Theresa Newlove; Henry Ukpeh; Anupam Chakrapani; Mary Anne Preece; Sarah Ball; James Pitt; Hilary D Vallance; Marion Coulter-Mackie; Hien Nguyen; Lin-Hua Zhang; Amit P Bhavsar; Graham Sinclair; Abdul Waheed; Wyeth W Wasserman; Sylvia Stockler-Ipsiroglu
Journal:  Am J Hum Genet       Date:  2014-02-13       Impact factor: 11.025

9.  Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents.

Authors:  Leigh Goedeke; Jamie Bates; Daniel F Vatner; Rachel J Perry; Ting Wang; Ricardo Ramirez; Li Li; Matthew W Ellis; Dongyan Zhang; Kari E Wong; Carine Beysen; Gary W Cline; Adrian S Ray; Gerald I Shulman
Journal:  Hepatology       Date:  2018-12       Impact factor: 17.425

10.  The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-β-D-glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer metabolism.

Authors:  Woo Sik Yu; Soo-Jin Jeong; Ji-Hyun Kim; Hyo-Jung Lee; Hyo Sook Song; Min-Seok Kim; Eunjung Ko; Hyo-Jeong Lee; Jae-Ho Khil; Hyeung-Jin Jang; Young Chul Kim; Hyunsu Bae; Chang Yan Chen; Sung-Hoon Kim
Journal:  Mol Cells       Date:  2011-05-24       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.